
 [
{
"symbol" : "524372",
"exchange" : "BOM",
"id": "678029",
"t" : "524372",
"e" : "BOM",
"name" : "Orchid Pharma Ltd"
, "f_reuters_url" : "http:\u002F\u002Fstocks.us.reuters.com\u002Fstocks\u002Fratios.asp?rpc=66\u0026symbol=",
"f_recent_quarter_date" : "",
"f_annual_date" : "",
"f_ttm_date" : "",
"financials" :
[{
"f_type" : "Income\u0026nbsp\u003BStatement"
,"url" : "http:www.google.comfinance?fstype=ii&q=BOM:524372"
,"f_figures" :
[
]
},
{
"f_type" : "Balance\u0026nbsp\u003BSheet"
,"url" : "http:www.google.comfinance?fstype=bi&q=BOM:524372"
,"f_figures" :
[
]
},
{
"f_type" : "Cash\u0026nbsp\u003BFlow"
,"url" : "http:www.google.comfinance?fstype=ci&q=BOM:524372"
,"f_figures" :
[
]
}],
"kr_recent_quarter_date" : "Q1 (Mar \u002709)",
"kr_annual_date" : "2017",
"kr_ttm_date" : "TTM",
"keyratios" :
[
{
"title" : "Net profit margin",
"recent_quarter" : "7.09%",
"annual" : "-61.58%",
"ttm" : "-3.54%"
},
{
"title" : "Operating margin",
"recent_quarter" : "11.17%",
"annual" : "-28.45%",
"ttm" : "-2.45%"
},
{
"title" : "EBITD margin",
"recent_quarter" : "",
"annual" : "10.94%",
"ttm" : "18.56%"
},
{
"title" : "Return on average assets",
"recent_quarter" : "",
"annual" : "-13.59%",
"ttm" : ""
},
{
"title" : "Return on average equity",
"recent_quarter" : "",
"annual" : "",
"ttm" : ""
},
{
"title" : "Employees",
"recent_quarter" : "1,800",
"annual" : "-",
"ttm" : "-"
}
]
, "c" : "+0.40",
"l" : "16.90",
"cp" : "2.42",
"ccol" : "chg",
"op" : "16.70",
"hi" : "17.20",
"lo" : "16.45",
"vo" : "70,107.00",
"avvo" : "",
"hi52" : "39.70",
"lo52" : "15.45",
"mc" : "1.49B",
"pe" : "",
"fwpe" : "",
"beta" : "",
"eps" : "-7.14",
"dy" : "",
"ldiv" : "",
"shares" : "88.96M",
"instown" : "",
"eo":""
, "related" : [
{
"id" : "678029",
"name" : "Orchid Pharma Ltd",
"t" : "524372",
"e" : "BOM",
"l" : "16.90",
"c" : "+0.40",
"mc" : "1.49B",
"cp" : "2.42",
"ccol" : "chg"
}
,
{
"id" : "6813187",
"name" : "Nectar Lifesciences Ltd.",
"t" : "NECLIFE",
"e" : "NSE",
"l" : "31.85",
"c" : "-0.35",
"mc" : "7.16B",
"cp" : "-1.09",
"ccol" : "chr"
}
,
{
"id" : "986830",
"name" : "Parabolic Drugs Limited",
"t" : "PARABDRUGS",
"e" : "NSE",
"l" : "8.65",
"c" : "-0.05",
"mc" : "535.37M",
"cp" : "-0.57",
"ccol" : "chr"
}
,
{
"id" : "7489710",
"name" : "Brooks Laboratories Ltd",
"t" : "BROOKS",
"e" : "NSE",
"l" : "94.00",
"c" : "-0.30",
"mc" : "1.51B",
"cp" : "-0.32",
"ccol" : "chr"
}
,
{
"id" : "2057138",
"name" : "Ankur Drugs and Pharma Ltd.",
"t" : "ANKURDRUGS",
"e" : "NSE",
"l" : "0.00",
"c" : "-4.55",
"mc" : "",
"cp" : "-100.00",
"ccol" : "chr"
}
,
{
"id" : "6462769",
"name" : "Torrent Pharmaceuticals Ltd",
"t" : "TORNTPHARM",
"e" : "NSE",
"l" : "1,357.35",
"c" : "+20.80",
"mc" : "227.74B",
"cp" : "1.56",
"ccol" : "chg"
}
,
{
"id" : "16546949",
"name" : "Lincoln Pharmaceuticals Ltd",
"t" : "531633",
"e" : "BOM",
"l" : "239.25",
"c" : "+9.05",
"mc" : "4.77B",
"cp" : "3.93",
"ccol" : "chg"
}
,
{
"id" : "3033292",
"name" : "Hiran Orgochem Ltd",
"t" : "506170",
"e" : "BOM",
"l" : "0.48",
"c" : "0.00",
"mc" : "46.10M",
"cp" : "0.00",
"ccol" : "chb"
}
,
{
"id" : "20411139269060",
"name" : "Medico Remedies Ltd",
"t" : "540937",
"e" : "BOM",
"l" : "97.00",
"c" : "0.00",
"mc" : "402.47M",
"cp" : "0.00",
"ccol" : "chb"
}
,
{
"id" : "10555516",
"name" : "Lupin Limited",
"t" : "LUPIN",
"e" : "NSE",
"l" : "822.00",
"c" : "+14.50",
"mc" : "370.74B",
"cp" : "1.80",
"ccol" : "chg"
}
,
{
"id" : "805988453466693",
"name" : "Sakar Healthcare Ltd",
"c" : "",
"mc" : "",
"cp" : "",
"ccol" : ""
}
]
, "summary" : [{
"address": "Orchid Towers 313-Valluvar Kottam High, Nungambakkam, CHENNAI, 600034, India",
"phone": "+91-44-25211000",
"fax": "+91-44-28211002",
"url": "http:\u002F\u002Fwww.orchidpharma.com",
"overview" : "Orchid Pharma Limited, formerly Orchid Chemicals \u0026 Pharmaceuticals Limited, is an India-based pharmaceutical company. The Company is involved in the development, manufacture and marketing of various bulk actives, formulations and nutraceuticals. The Company offers formulations (domestic) for cardiovascular, including ESAMLO - AT 10\u0027S, ESAMLO 2.5 10\u0027S, ESAMLO 5 10\u0027S, INDAP 2.5 10\u0027S, INDAP AT 10\u0027S and LOSAVAS 25 10\u0027S\u003B anti-diabetic, including G.REG 10\u0027S, G.REG SR 1000 10\u0027S, G.REG SR 500 10\u0027S and GLIMTIDE 1 10\u0027S\u003B neuropsychiatry, including ALZEPIL 10 10S, ALZEPIL 5 10S, 2-DEP-20, 2-DEP-30 and AMICHLOR 10\u0027S, and nutritional supplements, including Cefotaxime Sodium (Sterile), Ceftriaxone Sodium (Sterile), Cefazolin Sodium (Sterile), Cefoxitin Sodium (Sterile), Cefotiam Hexetil, Cefotiam Hydrochloride and Cefozopran Hydrochloride. It offers active pharmaceutical ingredients (API), including Cephalosporins-Orals, Cephalosporins-Injectibles, Veterinary Products and Non-Antibodies."
} ]
, "management" : [
{
"name" : "L. Chandrasekar",
"age" : "53",
"title" : "Chief Financial Officer, Executive Vice President - Finance, Compliance Officer, Company Secretary"
}
,
{
"name" : "S. Mani",
"title" : "President – Process Research, SH\u0026E and CSR"
}
,
{
"name" : "V. Vijayendran",
"title" : "Chief Executive – Domestic Formulations"
}
,
{
"name" : "P. N. Deshpande",
"title" : "Executive Vice President - Manufacturing"
}
,
{
"name" : "J. Surya Kumar",
"title" : "Senior Vice President - Formulation Development"
}
,
{
"name" : "U. P. Senthil Kumar",
"title" : "Senior Vice President - Process Research"
}
,
{
"name" : "V. S. Padalkar",
"title" : "Senior Vice President – Engineering \u0026 Production"
}
,
{
"name" : "B. Gopalan",
"age" : "62",
"title" : "Chief Scientific Officer"
}
,
{
"name" : "Deepak M. B. Nayyar",
"title" : "Vice President - Domestic Formulations"
}
,
{
"name" : "Sampath Parthasarathy",
"title" : "Vice President - Domestic Formulations"
}
]
,"moreresources" : [
]
}]
